ACET Q3 2018 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$72M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$9M

Net Income

-$8M

EPS (Diluted)

$-5.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$629,000

Free Cash Flow

$629,000

Stock-Based Comp.

$629,000

Balance Sheet

Total Assets

$117M

Total Liabilities

$8M

Stockholders' Equity

$109M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$3,000	+100.0%
Operating Income	-$9M	-$4M	-128.9%
Net Income	-$8M	-$3M	-154.0%

Revenue Segments

Human Health

$81M49%

Performance Chemicals

$45M27%

Pharmaceutical Ingredients

$39M24%